NCT06728072View on ClinicalTrials.gov

Addition of Antibiotics to Upfront Treatment Regimen for Colorectal Cancer

PHASE2RecruitingINTERVENTIONAL
Enrollment

97

Participants

Timeline

Start Date

March 7, 2025

Primary Completion Date

July 1, 2035

Study Completion Date

July 1, 2035

Conditions
Colorectal CancerCRC
Interventions
DRUG

Standard of Care Chemotherapy + Metronidazole, ciprofloxacin, aspirin

Metronidazole, ciprofloxacin, aspirin is initiated Cycle 1 Day 1 of chemotherapy. May be initiated any time from 7 days before Cycle 1 Day 1 up to and including Cycle 1 Day 3

Trial Locations (1)

23298

RECRUITING

Virginia Commonwealth University, Richmond

All Listed Sponsors
collaborator

American Cancer Society, Inc.

OTHER

lead

Virginia Commonwealth University

OTHER